Zegalogue will be available in both an auto injector and a prefilled syringe for the treatment of severe hypoglycemia in patients with diabetes age 6 or older Approval based on results from three ...
Copenhagen, DK and Boston, MA, U.S. June 24, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) a biotechnology company focused on the discovery, development and commercialization of ...
The product should be stored in a refrigerator but can be kept at room temperature for up to 12 months. Zegalogue ® (dasiglucagon) injection is now available for the treatment of severe hypoglycemia ...
Copenhagen, DK and Boston, MA, U.S. August 12, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) a biotechnology company focused on the discovery, development and commercialization of ...
Please provide your email address to receive an email when new articles are posted on . The approval of Zegalogue injection 0.6 mg (Zealand Pharma) is based on results from three trials with children ...
Zegalogue (dasiglucagon) is a brand-name drug prescribed for severe low blood sugar in certain adults and some children. Zegalogue comes as a solution for subcutaneous injection. It’s injected only as ...
Agreement includes an upfront payment, development, regulatory, manufacturing and sales-based milestones of up to DKK 290 million to Zealand in addition to high-single to low-double digit royalties on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results